What Does it Mean to be in the NSMP Category of Uterine Cancer?
Stephanie Gaillard, MD PHD, Director, Gynecologic Cancer Trials and Co-Director, Developmental Therapeutics/Phase I Clinical Trials Program, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center. Dr. Gaillard will explain what the No Specific Molecular Profile (NSMP) category of endometrial/uterine cancer is and tell us about the research that is going on in the various subcategories of NSMP. […]
Uterine Sarcoma: What You Need to Know
Join Dr. Nita Lee, Gynecologic Oncologist and expert in rare uterine cancers at the University of Chicago Comprehensive Cancer Center, for a discussion on uterine sarcoma—an often overlooked and aggressive form of cancer. Dr. Lee shares the most current advancements in diagnosis, treatment options, and ongoing research, shedding light on this rare disease and what […]
Living with Metastatic Lobular Breast Cancer (mILC): Challenges, Treatment, and New Developments
Join us for an informative webinar focused on metastatic lobular breast cancer (mILC). In this session, Dr. Sherry Shen, a breast medical oncologist at MSK, will provide insights into the unique challenges of mILC, explain how it differs from other types of breast cancer, and discuss the latest advancements in treatment. This is a great […]
Let’s Talk About It: Gynecologic Cancer (Beating Brain Fog)
Cancer survivors often use the term “brain fog” to describe the heavy and cumbersome feeling of lacking mental clarity. Chemobrain can be a side effect of chemotherapy, resulting in difficulty remembering details, multi-tasking, or staying focused through longer tasks. In addition to the impact of cancer treatments, the diagnosis of cancer itself can be stressful, […]
What Happens After Ovarian Cancer Treatment?
You’ve been treated for ovarian cancer. Now what? You may have questions about maintenance therapy, surveillance guidelines after initial treatment, tests you may receive, how to watch for symptoms that could indicate a recurrence, and more. Dr. Brittany Lees, a gynecologic oncologist at Atrium Health Levine Cancer Institute, will delve into what happens after treatment […]
In a Nutshell: HIPEC and Ovarian Cancer
Hyperthermic intraperitoneal chemotherapy (HIPEC), also known as “hot chemotherapy,” is a treatment for ovarian cancer, but it is controversial. In this brief conversation with Dr. Ernest Han, a gynecologic oncologist at City of Hope, we’ll discuss HIPEC, how it works, what the research says, and why there is a lack of consensus surrounding this treatment […]
Language Access: Understanding Your Rights
Getting a cancer diagnosis can be scary, especially if you don’t speak the same language as your healthcare team. But everyone deserves good care, and there are resources to help you understand your options in any language. Join us for a special talk about patient rights, language access, and how to speak up to make […]
Cannabis for Chronic Pain Management
Pain is a common challenge for many cancer patients, particularly those experiencing severe joint or nerve pain from medications aimed at reducing recurrence or managing ongoing treatment. Join us for an insightful session with Kevin Boehnke, PhD, an Assistant Professor from the University of Michigan’s Chronic Pain & Fatigue Research Center who is also a […]
Fertility-Sparing Treatment for Gynecologic Cancer
For those of reproductive age who want to have biological children, fertility is a vital consideration following a diagnosis of gynecologic cancer. While treatment is essential for survival, it can impact reproductive health. Join Dr. Katherine Mager, a gynecologic oncologist at Roswell Park Comprehensive Cancer Center, for an engaging discussion on fertility-sparing treatment of gynecologic […]